Professor | Qi Yin | Asia Growth Partners

Name	Qi Yin
Contact Information	qyin@simm.ac.cn
Language ability	Chinese, English
Province	Shanghai

Name

Qi Yin

Contact Information

qyin@simm.ac.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2007-09--2012-06 PhD in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Work Experience	2020-10~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher 2014-10~2020-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher 2012-07~2014-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher 2007-09~2012-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - PhD in Science
Awards	First Prize (2023): Key technology and application of formulations to improve the in vivo delivery efficiency of poorly soluble drugs Second Prize (2020): Basic research on the application of new nano drug delivery systems to overcome tumor chemotherapy resistance First Prize (2020): Research on drug delivery systems to improve the efficacy of poorly soluble drugs and the druggability of candidate drugs Sanofi-Shanghai Institute of Biological Sciences Outstanding Young Talent Award (2019) First Prize (2015): Chinese Pharmaceutical Association Science and Technology Award First Prize (2013): Shanghai Pharmaceutical Science and Technology Award

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2007-09--2012-06 PhD in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Work Experience

2020-10~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher
2014-10~2020-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
2012-07~2014-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
2007-09~2012-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - PhD in Science

Awards

First Prize (2023): Key technology and application of formulations to improve the in vivo delivery efficiency of poorly soluble drugs
Second Prize (2020): Basic research on the application of new nano drug delivery systems to overcome tumor chemotherapy resistance
First Prize (2020): Research on drug delivery systems to improve the efficacy of poorly soluble drugs and the druggability of candidate drugs
Sanofi-Shanghai Institute of Biological Sciences Outstanding Young Talent Award (2019)
First Prize (2015): Chinese Pharmaceutical Association Science and Technology Award
First Prize (2013): Shanghai Pharmaceutical Science and Technology Award

Areas of Focus	Tumor-targeted drug delivery based on nanotechnology
Publications	Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer, Qi Yin, 2023 Promote intratumoral drug release and penetration to counteract docetaxel-induced metastasis by photosensitizer-modified red blood cell membrane-coated nanoparticle, Qi Yin, 2023 Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy, Qi Yin, 2023 Breaking tumor immunosuppressive network by regulating multiple nodes with triadic drug delivery nanoparticles, Qi Yin, 2023 Nanosized drug delivery systems modulating immunosuppressive microenvironment for improving cancer immunotherapy, Qi Yin, 2022 Anti-hypoxia nanosized drug delivery systems improving cancer therapy, Qi Yin, 2022 Nano drug delivery systems improve metastatic breast cancer therapy, Qi Yin, 2021 Gut microbiota: influence on carcinogenesis and modulation strategies by drug delivery systems to improve cancer therapy, Qi Yin, 2021 Ternary regulation of tumor microenvironment by heparanase-sensitive micelle-loaded monocytes improves chemo-immunotherapy of metastatic breast cancer, Qi Yin, 2021 Calcitriol-loaded dual-pH-sensitive micelle counteracts pro-metastasis effect of paclitaxel in triple-negative breast cancer therapy, Qi Yin, 2020 Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer, Qi Yin, 2019 In vivo environment-adaptive nanocomplex with tumor cell-specific cytotoxicity enhances T cells infiltration and improves cancer therapy, Qi Yin, 2019 Cocktail strategy based on spatio-temporally controlled nano device improves therapy of breast cancer, Qi Yin, 2019

Areas of Focus

Tumor-targeted drug delivery based on nanotechnology

Publications

Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer, Qi Yin, 2023
Promote intratumoral drug release and penetration to counteract docetaxel-induced metastasis by photosensitizer-modified red blood cell membrane-coated nanoparticle, Qi Yin, 2023
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy, Qi Yin, 2023
Breaking tumor immunosuppressive network by regulating multiple nodes with triadic drug delivery nanoparticles, Qi Yin, 2023
Nanosized drug delivery systems modulating immunosuppressive microenvironment for improving cancer immunotherapy, Qi Yin, 2022
Anti-hypoxia nanosized drug delivery systems improving cancer therapy, Qi Yin, 2022
Nano drug delivery systems improve metastatic breast cancer therapy, Qi Yin, 2021
Gut microbiota: influence on carcinogenesis and modulation strategies by drug delivery systems to improve cancer therapy, Qi Yin, 2021
Ternary regulation of tumor microenvironment by heparanase-sensitive micelle-loaded monocytes improves chemo-immunotherapy of metastatic breast cancer, Qi Yin, 2021
Calcitriol-loaded dual-pH-sensitive micelle counteracts pro-metastasis effect of paclitaxel in triple-negative breast cancer therapy, Qi Yin, 2020
Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer, Qi Yin, 2019
In vivo environment-adaptive nanocomplex with tumor cell-specific cytotoxicity enhances T cells infiltration and improves cancer therapy, Qi Yin, 2019
Cocktail strategy based on spatio-temporally controlled nano device improves therapy of breast cancer, Qi Yin, 2019

Nanotechnology Tumor Drug Delivery Targeted Therapy Cancer Nanoparticles Chemotherapy Immunotherapy Drug Resistance Biomedical Research

Songmei Liu - Wuhan University

Yan Liu - Wuhan University

Min Peng - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us